Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao Sells 90,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $14.23, for a total transaction of $1,280,700.00. Following the sale, the chief executive officer now owns 2,183,100 shares in the company, valued at approximately $31,065,513. This trade represents a 3.96 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Alignment Healthcare Stock Up 1.0 %

ALHC stock opened at $14.52 on Thursday. The stock has a market capitalization of $2.78 billion, a P/E ratio of -18.86 and a beta of 1.50. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $15.82. The business has a fifty day moving average price of $12.88 and a 200-day moving average price of $11.54.

Analysts Set New Price Targets

A number of brokerages have weighed in on ALHC. Barclays upped their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. UBS Group upped their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Stifel Nicolaus raised their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Finally, Stephens reissued an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $11.88.

Institutional Investors Weigh In On Alignment Healthcare

Several large investors have recently bought and sold shares of the business. R Squared Ltd purchased a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $55,000. nVerses Capital LLC bought a new stake in Alignment Healthcare in the 3rd quarter worth approximately $95,000. Ballentine Partners LLC purchased a new stake in Alignment Healthcare during the 4th quarter valued at $121,000. Aigen Investment Management LP purchased a new stake in Alignment Healthcare during the 4th quarter valued at $129,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare during the 3rd quarter valued at $131,000. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.